The company behind an imaging agent meant to identify prostate cancer said it received FDA approval on Thursday for use in patients with suspected metastasis or recurrence. Lantheus Holdings, Inc.

Prostate cancer is the second most common cancer in men, with over 288,000 new cases diagnosed each year. It is also one of the most curable cancers if detected early. A new imaging tool is helping ...

SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer prognostic ...

Each year, more than one million men in the United States have a prostate biopsy due to an elevated PSA. The majority of these biopsies show either no prostate cancer or low-risk cancer, meaning the ...

England is testing a new artificial intelligence (AI) tool to speed prostate cancer diagnoses, which may save men from weeks of uncertainty about their health. The tool, which will be piloted through ...

Researchers from the The Institute of Cancer Research, London (ICR) and the University of Cambridge have revealed a newly created comprehensive tool, CanRisk-Prostate, for predicting an individual’s ...

Joseph Camunas lost his father to prostate cancer. And his younger brother was diagnosed with the disease at age 50. So when doctors found a slight elevation in his annual PSA blood test, Camunas wasn ...

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict ...

Prostate cancer experts have developed an updated version of the Partin Tables, a tool to help men diagnosed with prostate cancer and their doctors to better assess their chance of a surgical cure.